Current Medicinal Chemistry

Editor-in-Chief

Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge
Cambridge
(UK)

Nobel Laureates on Editorial Board

Prof. John Gurdon
(UK)

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 21 Issue: 5, February 2014

Inhibitors and Prodrugs Targeting CYP1: A Novel Approach in Cancer Prevention and Therapy

Volume:21   Issue: 5
Pp: 519-552
Jiahua Cui and Shaoshun Li
DOI: 10.2174/09298673113206660277
Published on: 29 September, 2013

Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?

Volume:21   Issue: 5
Pp: 553-574
S. Nag, X. Zhang, K.S. Srivenugopal, M.-H. Wang, W. Wang and R. Zhang
DOI: 10.2174/09298673113206660325
Published on: 01 November, 2013

Ellipticines as DNA-Targeted Chemotherapeutics

Volume:21   Issue: 5
Pp: 575-591
Marie Stiborova and Eva Frei
DOI: 10.2174/09298673113206660272
Published on: 16 September, 2013

Shikimate Kinase, a Protein Target for Drug Design

Volume:21   Issue: 5
Pp: 592-604
J.D. Coracini and W.F. de Azevedo
DOI: 10.2174/09298673113206660299
Published on: 24 October, 2013

Nanomedicine Against Malaria

Volume:21   Issue: 5
Pp: 605-629
Patricia Urban and Xavier Fernandez-Busquets
DOI: 10.2174/09298673113206660292
Published on: 23 October, 2013

Endocrine Disruptor Agent Nonyl Phenol Exerts An Estrogen-like Transcriptional Activity on Estrogen Receptor Positive Breast Cancer Cells

Volume:21   Issue: 5
Pp: 630-640
A.A. Amaro, A.I. Esposito, V. Mirisola, A. Mehilli, C. Rosano, D.M. Noonan, A. Albini, U. Pfeffer and G. Angelini
DOI: 10.2174/09298673113209990169
Published on: 26 June, 2013

OA-4 Inhibits Osteoclast Formation and Bone Resorption via Suppressing RANKL Induced P38 Signaling Pathway

Volume:21   Issue: 5
Pp: 641-649
B. Tian, A. Qin, Z.Y. Shao, T. Jiang, Z.J. Zhai, H.W. Li, T.T. Tang, Q. Jiang, K.R. Dai, M.H. Zheng, Y.P. Yu and Z.A. Zhu
DOI: 10.2174/09298673113209990190
Published on: 23 July, 2013